News
The section includes updates and press releases from hepCoalition and partner organizations. Includes highlights of upcoming events, actions, and important meetings.
Calendar
Curated list of key international conferences and meetings related to hepatitis C, substance user health, and harm reduction.
Partner News
The section includes updates from partner organizations on related advocacy efforts.
Digitalized Community-led Monitoring - HIV/HBV/HCV in India and Indonesia
TREAT Asia/amfAR is implementing the Community-led Monitoring in Asia project, an online data dashboard to enhance ongoing community-led monitoring in India and Indonesia, including HBV and HCV indicators. More
Barriers to a Cure: Study Reveals Global Obstacles to Getting Hep C Treatment
A study provides new evidence regarding the registration and reimbursement of HCV therapies, including restrictions on reimbursement, permitting multicountry analyses and highlighting areas for growth. More
Press Releases
Press releases from hepCoalition and partner organizations.
Treatment for Hepatitis C: The Patent System is Standing in the Way of Access to Medicine
Following the appeal filed by AIDES, Médecins du Monde and Médecins sans Frontières, the European Patent Office has decided to uphold the patent of sofosbuvir, hindering the launch of an affordable generic version of the drug in Europe. More
TAG Welcomes Addition of Ravidasvir to WHO Essential Medicines List for Treatment of Hepatitis C Virus
Ravidasvir is the first HCV cure to be developed through South-South collaboration and with funding and clinical support from non-profit organizations. It is now recommended for use in combination with sofosbuvir as an alternative pangenotypic DAA. More
